Stay updated with breaking news from Synerkine Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press Release Stockholm, Sweden, November 13, 2023 The shareholders of Mendus AB , reg. no 556629-1786, are hereby invited to the Extraordinary General Meeting on Wednesday, 13...
Synerkine Pharma, a biopharmaceutical company based in Leiden has successfully secured €5.3M in an extension of its Series A financing.
Synerkine Pharma Raises EUR 3.5 Million in an Extended Series A Financing - read this article along with other careers information, tips and advice on BioSpace